Home » Topics » BioWorld Science

BioWorld Science
RSS

Oyster Point expands its pipeline and announces promising preclinical data

June 4, 2021

China's NMPA accepts IND application for CT-120, a dual-antigen specific CAR-T therapy

June 4, 2021

Corbus licenses integrin-targeting MAbs, CRB-601 and CRB-602

June 4, 2021

Bispecific antibody may allow safer targeting of the IL-2 signaling pathway

June 4, 2021

Fecal microbiota transplantation used to create autism model in rat offspring

June 4, 2021

SSTR5 splice variant sst5TMD4 for diagnosis and prognosis of high-grade gliomas

June 4, 2021

Mindset selects its lead next-generation psychedelic candidate, MSP-1014

June 3, 2021

Replimune provides updated clinical data for RP-1 and RP-2 programs

June 3, 2021

U.K. study identifies another danger of COVID-19: increased antibiotic resistance

June 3, 2021

New biomarkers identified for diagnosis of Cushing's syndrome

June 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...